Participated · Equity · Jul 2026

Silicon Microgravity commercialises MEMS-based sensing technologies spun out of Cambridge University, developing high-performance accelerometers, gyroscopes and MEMS gravimeters. The company targets two primary markets: inertial navigation—offering smaller, higher-accuracy MEMS accelerometers and gyroscopes—and gravity sensing, providing compact gravimeters for surveys and alternative navigation. Its technology is positioned for applications across defence, space, aerospace, robotics and geophysics, and the company says its MEMS accelerometers are already supporting advanced space programmes and satellite-enabled mineral exploration. SMG emphasizes production for extreme operating environments and is focused on scaling UK manufacturing and semiconductor production capacity. Early support included BP during development for oil and gas applications, and the company reports growing commercial validation from global customers and partners.

Participated · Seed · Jul 2026

Revolver Therapeutics was spun out of the University of Bath to commercialize a proprietary Transcription Block Survival platform that discovers cell-penetrating peptides designed to inhibit transcription factors. The company focuses on producing first-in-class, cell-penetrating peptide therapeutics and is advancing initial assets into colorectal cancer. Company scientists report they have demonstrated stopping tumour cell growth in laboratory studies and have addressed challenges of intracellular delivery. Revolver has received institutional backing including UKI2S (which first invested in 2024), QantX, and support from the University of Bath’s Technology Transfer team. The recent £572k round will fund further platform development and progression of its pipeline toward therapeutic candidates for cancers with unmet needs.

Led · Seed · May 2026

K3Metrology commercialises metrology technology developed at the National Physical Laboratory to allow manufacturers to measure multiple points simultaneously and continuously during assembly. The system is designed to identify alignment issues in real time, reducing production downtime and late-stage rework, particularly for high-value sectors such as aerospace. The company has relocated to the Advanced Manufacturing Research Centre in North Wales to deepen engagement with industrial partners and accelerate commercial deployment. Funding from the recent seed round will expand the engineering team, accelerate industrial trials and support early deployments. The technology represents the translation of around 15 years of NPL research into an industrial capability. The article does not disclose revenue, users, or prior financing metrics.

Participated · Seed · Apr 2026

Spaceflux builds AI-powered space intelligence products and capabilities for analyzing space data. The company is focused on developing a next generation of AI-driven space intelligence offerings and expanding globally. Its most recent financing brought total seed funding to £9M following a £3.5M extension. Investors include Blackfinch Ventures, Foresight Group, the UK Innovation & Science Seed Fund (managed by Future Planet Capital) and SPARX Asset Management’s Space Frontiers Fund II. The participation of UKI2S reflects government-backed support linked to partners such as the UK Space Agency and the UK Ministry of Defence. Spaceflux also appointed General Sir Chris Deverell KCB MBE to its board amid this funding update.

Participated · Equity · Apr 2026

Ascension develops processes to recover critical minerals from geothermal resources. The company recently announced it secured funding to advance those recovery efforts. The article did not provide details on products, revenues, users, or other operating metrics. It also did not disclose the size of the financing, investors, or previous funding history. The funding announcement signals continued development of Ascension's geothermal critical mineral recovery activities.